N-0861  

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameN-0861  
Drug Alias NameN-0861
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionAdenosine A1 receptor agonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAderis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAderis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A